Generative AI for drug discovery - AI tools

Insilico Medicine utilizes generative artificial intelligence and robotics to accelerate drug discovery and development, aiming to reduce the time and cost of bringing new medications to patients.

• Contact for Pricing

Menten AI offers an advanced generative AI platform specifically designed for peptide therapeutics, overcoming traditional drug design limitations through machine learning and physics-based molecular modeling.

• Contact for Pricing

Enki Platform is the first commercially accessible foundation model for small molecules, specializing in drug discovery with coverage for over 300 GPCR and kinase targets.

• Contact for Pricing

Pharma.ai is a commercially-available generative AI and automation platform designed to enhance the quality and productivity of pharmaceutical research.

• Contact for Pricing

Iambic is an AI-driven drug discovery platform. It leverages cutting-edge AI and physics-based algorithms to address challenging design problems and deliver optimized medicines.

• Contact for Pricing

BullFrog AI is a technology-enabled drug discovery company leveraging artificial intelligence to advance the next generation of life-saving medicine. Their AI-powered platform accelerates research and development, lowers costs, and improves the success rate of developing new therapeutics.

• Contact for Pricing

Aqemia is a next-generation pharmatech company that combines quantum-inspired physics and machine learning to accelerate drug discovery, operating 10,000x faster than traditional methods.

• Contact for Pricing

BenevolentAI accelerates drug discovery by leveraging its proprietary AI platform, the Benevolent Platform™, to generate novel insights and increase the probability of clinical success.

• Contact for Pricing

Aitia is an AI-enabled biotech company accelerating drug discovery and development using causal AI and Gemini Digital Twins derived from multi-omic patient data.

• Contact for Pricing

Nabla Bio develops integrated AI and wet-lab technologies for de novo antibody design. The platform focuses on creating superior manufacturability, safety, and efficacy in drugs.

• Contact for Pricing